Product Images Norliqva
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Norliqva NDC 46287-035 by Cmp Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - norliquid 01
Figure 1 - Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo - norliquid 02
Figure 2 – Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups - norliquid 03
This is a table of clinical trial results for a medication called Amlodipine compared to a placebo. The table shows the number of patients in different categories according to age, gender, baseline sitting SBP, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strategies. It also shows the Hazard Ratio (with 95% Confidence Interval) for each group.*
PRINCIPAL DISPLAY PANEL - 150 mL Bottle Label - norliquid 04
Norligva is an oral solution medication containing 1mg of amlodipine besylate per mL. The recommended dosage is provided in the prescribing information. The medication contains 4% alcohol and should be stored between 20°C to 25°C. Children should not have access to Norligva, and it should not be dispensed to patients outside of the original packaging. It is distributed by CMP Pharma, Inc., and has an NDC number of 46267-035-15.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.